Vanderbilt-Ingram Cancer Center Archive — Page 27 of 29
-
August 29, 2007
Prostate cancer patients may be eligible for less invasive therapy; Vanderbilt-Ingram Cancer Center first in state to test new ultrasound procedure
Men with prostate cancer now may have access to a new, minimally invasive surgical procedure. Urologic surgeons at Vanderbilt-Ingram Cancer Center will be the first in Tennessee to test the new Ablatherm procedure, which uses high-intensity focused ultrasound (HIFU) to destroy cancerous prostate tissue without any incision. -
February 23, 2007
Vanderbilt-Ingram clinic space expanding to meet needs of patients
When the dust settles on a new renovation project involving Vanderbilt-Ingram Cancer Center‘s Henry-Joyce Cancer Clinic, waiting room space and exam rooms will nearly double to help meet the needs of an ever increasing number of cancer patients in Middle Tennessee and beyond. -
February 22, 2007
Vanderbilt-Ingram Cancer Center Receives Highest Level of Approval
Vanderbilt-Ingram Cancer Center has received a three-year accreditation with commendation, the highest level of approval, from the Commission on Cancer of the American College of Surgeons (ACoS). -
January 29, 2007
Vanderbilt-Ingram Cancer Center receives $6.5 million grant to study tumor environment
Like a seed needs soil to grow and flourish, a tumor relies on its environment to grow and spread in the body -- something the Vanderbilt-Ingram Cancer Center will be exploring more closely with the help of a new $6.5 million grant from the National Cancer Institute (NCI). -
January 29, 2007
Pietenpol Named Interim Director of Vanderbilt-Ingram Cancer Center
Jennifer A. Pietenpol, Ph.D., has been selected to lead the Vanderbilt-Ingram Cancer Center as interim director. -
January 10, 2007
Vanderbilt-Ingram Cancer Center Director To Return To Home State For Post At MD Anderson
Raymond DuBois Jr., M.D., Ph.D., will leave his position as director of the Vanderbilt-Ingram Cancer Center later this year to return to his native Texas as provost and executive vice president of academic affairs at M.D. Anderson Cancer Center in Houston. -
November 28, 2006
Vanderbilt-Ingram Cancer Center, AstraZeneca Form Master Agreement to Streamline Research Collaborations
The Vanderbilt-Ingram Cancer Center and AstraZeneca have developed a master scientific agreement to streamline and integrate collaborations in basic, translational and clinical cancer research, officials with the company and cancer center announced today.